Li Pang

机构：Central South University, Sun Yat-sen University, Sun Yat-sen Memorial Hospital, National Clinical Research, PharmacoGenetics (China), Xiangya Hospital Central South University · ORCID：0000-0002-7163-6255

发表论文 111 篇 · 总被引 2227 次 · h-index 26

代表论文

• Cross‐tissue multi‐omics analyses reveal the gut microbiota's absence impacts organ morphology, immune homeostasis, bile acid and lipid metabolism (2025 · iMeta · 被引 27)
• Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation (2024 · Cancer Immunology Immunotherapy · 被引 11)
• Precise In Situ Delivery of a Photo-Enhanceable Inflammasome-Activating Nanovaccine Activates Anticancer Immunity (2024 · Cancer Research · 被引 7)
• Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options (2024 · Transplantation Proceedings · 被引 6)
• Short-term prognosis of recipients with pretransplant exposure to immune checkpoint inhibitors after liver transplantation for hepatocellular carcinoma: A retrospective cohort study (2025 · Liver Research · 被引 5)
• Continuing immune checkpoint inhibitors after pseudoprogression improves survival in lung cancer patients: a systematic review and meta-analysis (2025 · Journal of Thoracic Disease · 被引 4)